Physician profile
Michael G Mcinnis
NPI 1033189956
$1,108.72
in general payments reported to CMS, 2019-2025
22 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $78.50 · 2021: $19.85 · 2023: $49.36 · 2024: $115 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $210.07 | 2019 | |
| Lilly USA, LLC | $132.87 | 2019-2024 | Jardiance |
| Abbott Laboratories | $93.73 | 2019-2025 | Freestyle Libre, Proclaim |
| Glaxosmithkline, LLC. | $72.86 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $72.22 | 2019-2024 | |
| Pfizer INC. | $66.51 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $60.25 | 2019-2023 | Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $42.20 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $41.28 | 2019 | |
| Amarin Pharma, INC. | $39.57 | 2019 | |
| Antares Pharma, INC. | $35.30 | 2019 | |
| Inspire Medical Systems, INC. | $34.96 | 2023 | Inspire |
| Teva Pharmaceuticals USA, INC. | $31.00 | 2019 | |
| Sanofi Pasteur INC. | $29.35 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $26.41 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $25.26 | 2020 | |
| Titan Pharmaceuticals, INC. | $24.55 | 2019 | |
| Amgen INC. | $16.65 | 2019 | |
| Mdd US Operations, LLC | $13.94 | 2019 | |
| Ironwood Pharmaceuticals, INC | $13.89 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.24 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcinnis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.